Vésale Bioscience, a company in the research and development of solutions and treatments using phage therapy for multi-resistant infections, has received €1.8 million in grants from the European Innovation Council (EIC) Accelerator Fund for its PhageDiag project. The project is a phagogram using artificial intelligence (AI) that enables decentralised diagnostics and personalised treatment. According to […]
